Thalamic atrophy is associated with development of clinically definite multiple sclerosis

. 2013 Sep ; 268 (3) : 831-41. [epub] 20130423

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid23613615

PURPOSE: To investigate the association between the development of thalamic and cortical atrophy and the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS). MATERIALS AND METHODS: This prospective study was approved by the institutional review board. Informed consent was given by 216 CIS patients, and patients were treated with 30 µg of intramuscular interferon β1a once a week. They were assessed with a magnetic resonance (MR) imaging examination at baseline, 6 months, 1 year, and 2 years. Patients were evaluated within 4 months of an initial demyelinating event, had two or more brain lesions on MR images, and had two or more oligoclonal bands in cerebrospinal fluid. MR imaging measures of progression included cumulative number and volume of contrast agent-enhanced (CE) new and enlarged T2 lesions, and changes in whole-brain, tissue-specific global, and regional gray matter volumes. Regression and mixed-effect model analyses were used. RESULTS: Over 2 years, 92 of 216 patients (42.6%) converted to CDMS; 122 (56.5%) CIS patients fulfilled McDonald 2005 criteria and 153 (70.8%) fulfilled McDonald 2010 criteria for MR imaging dissemination in time and space. The mean time to first relapse was 3.1 months, and mean annual relapse rate was 0.46. In mixed-effect model analysis, the lateral ventricle volume (P = .005), accumulation of CE (P = .007), new total T2 (P = .009) and new enlarging T2 lesions (P = .01) increase, and thalamic (P = .009) and whole-brain (P = .019) volume decrease were associated with development of CDMS. In multivariate regression analysis, decrease in thalamic volumes and increase in lateral ventricle volumes (P = .009) were MR imaging variables associated with the development of CDMS. CONCLUSION: Measurement of thalamic atrophy and increase in ventricular size in CIS is associated with CDMS development and should be used in addition to the assessment of new T2 and CE lesions.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Time course of lesion-induced atrophy in multiple sclerosis

. 2022 Aug ; 269 (8) : 4478-4487. [epub] 20220408

Monitoring of radiologic disease activity by serum neurofilaments in MS

. 2020 Jul ; 7 (4) : . [epub] 20200409

A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS

. 2019 Mar ; 40 (3) : 446-452. [epub] 20190228

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study

. 2018 ; 17 () : 444-451. [epub] 20171105

Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients

. 2015 Oct ; 56 (10) : 2010-8. [epub] 20150804

Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome

. 2015 Aug ; 36 (8) : 1457-64. [epub] 20150625

MRI correlates of disability progression in patients with CIS over 48 months

. 2014 ; 6 () : 312-9. [epub] 20140928

Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome

. 2014 Sep ; 261 (9) : 1735-44. [epub] 20140622

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...